The activation of tumor-specific CD8 + T cells relies on the cross-presentation of APC antigens, such as DCs or macrophages [55, 56], suggesting that CLEC1B may affect the antigen cross-presentation of APCs and immune activation. The gene discussed is CD8A; the disease is neoplasm.